# STunning in Acute Myocardial Infarction - BAS

Study · id `cardio:ct-nct06562582` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06562582](<https://clinicaltrials.gov/study/NCT06562582>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06562582

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT06562582. Randomized; no masking; primary purpose treatment. Start 2025-01-06 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT06562582, source copy `cardio:ctgov-nct06562582-2026-10-13`, retrieved 2026-10-26)
- Started: 2025-01-06 (actual) (ClinicalTrials.gov record NCT06562582, source copy `cardio:ctgov-nct06562582-2026-10-13`, retrieved 2026-10-26)
- Primary completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT06562582, source copy `cardio:ctgov-nct06562582-2026-10-13`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT06562582, source copy `cardio:ctgov-nct06562582-2026-10-13`, retrieved 2026-10-26)
- Countries: Sweden (ClinicalTrials.gov record NCT06562582, source copy `cardio:ctgov-nct06562582-2026-10-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06562582-2026-10-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: STunning in Acute Myocardial Infarction - BAS
- Acronym: STAMI-BAS
- Condition: Myocardial Infarct
- Intervention (Drug): Bisoprolol Oral Tablet
- Intervention (Drug): Ramipril Oral Product
- Intervention (Drug): Dapagliflozin Oral Product
- Lead sponsor: Vastra Gotaland Region
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Vastra Gotaland Region (`cardio:org-vastra-gotaland-region`)

## Provenance

Content hash: 87bd89d721db4492fb86111d0021e7d0e1c93fedbafe411bdccb1fe693413e68
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
